Advances in adenoviral vectors: from genetic engineering to their biology

被引:136
作者
Yeh, P
Perricaudet, M
机构
[1] CNRS URA 1301/Rhone-Poulenc Rorer G., Lab. de Genet. des Virus Oncogenes, Institut Gustave Roussy
[2] CNRS URA 1301/Rhone-Poulenc Rorer G., Lab. de Genet. des Virus Oncogenes, Institut Gustave Roussy, 94805 Villejuif Cedex
关键词
adenovirus; viral capsid; DNA replication; gutless;
D O I
10.1096/fasebj.11.8.9240963
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ad2 and Ad5 belong to a group of human cytolytic viruses that target the respiratory airways for reproduction, whereas latent infections establish within other tissues. Signals therefore exist that control this dichotomic process in different cell types, perhaps including cis and/or trans elements of viral origin. Since 1993, Ad2- and Ad5-based adenoviruses lacking all or part of the El regulatory region have been undergoing evaluation in phase I trials that target cancer and cystic fibrosis. These viruses are extremely attenuated and actually do not reproduce in most human cells. However, they retain most of the virus genetic program and often promote a significant cytotoxicity after infection, emphasizing the need to further cripple the virus biology to extend the duration of transgene expression, if required. We will review the strategies currently followed to engineer a professional lytic virus for epithelial cells into an innocuous gene delivery vehicle. Potential effects on the transducing properties of the vector that may result from the inactivation of viral activities that normally allow/regulate extrachromosomal gene expression during wild-type infection are discussed.
引用
收藏
页码:615 / 623
页数:9
相关论文
共 50 条
[31]   Retargeting adenoviral vectors to improve gene transfer into tumors [J].
R T Hogg ;
P Thorpe ;
R D Gerard .
Cancer Gene Therapy, 2011, 18 :275-287
[32]   Rescue of chimeric adenoviral vectors to expand the serotype repertoire [J].
Roy, Soumitra ;
Clawson, David S. ;
Lavrukhin, Oleg ;
Sandhu, Arbans ;
Miller, Jim ;
Wilson, James A. .
JOURNAL OF VIROLOGICAL METHODS, 2007, 141 (01) :14-21
[33]   The use of adenoviral vectors in gene therapy and vaccine approaches [J].
Araujo, Natalia Meneses ;
Rubio, Ileana Gabriela Sanchez ;
Toneto, Nicholas Pietro Agulha ;
Morale, Mirian Galliote ;
Tamura, Rodrigo Esaki .
GENETICS AND MOLECULAR BIOLOGY, 2022, 45 (03)
[34]   Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors [J].
Iampietro, M. Justin ;
Larocca, Rafael A. ;
Provine, Nicholas M. ;
Abbink, Peter ;
Kang, Zi Han ;
Bricault, Christine A. ;
Barouch, Dan H. .
JOURNAL OF VIROLOGY, 2018, 92 (11)
[35]   A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors [J].
Kraaij, Robert ;
van der Weel, Laura ;
de Ridder, Corrina M. A. ;
van der Korput, Hetty A. G. M. ;
Zweistra, Joke L. M. ;
van Rijswijk, Anglique L. C. T. ;
Bangnial, Chris H. ;
Trapman, Jan .
PROSTATE, 2007, 67 (08) :829-839
[36]   Peptide targeting of adenoviral vectors to augment tumor gene transfer [J].
E N Ballard ;
V T Trinh ;
R T Hogg ;
R D Gerard .
Cancer Gene Therapy, 2012, 19 :476-488
[37]   Adenoviral vectors transduce alveolar macrophages in lung cancer models [J].
Tippimanchai, Darinee D. ;
Nolan, Kyle ;
Poczobutt, Joanna ;
Verzosa, Gregory ;
Li, Howard ;
Scarborough, Hannah ;
Huang, Jing ;
Young, Christian ;
DeGregori, James ;
Nemenoff, Raphael A. ;
Malkoski, Stephen P. .
ONCOIMMUNOLOGY, 2018, 7 (06)
[38]   In vitro use of adenoviral vectors: Effects on salivary gland structure [J].
O'Connell, BC ;
Redman, RS ;
Zheng, CY .
EUROPEAN JOURNAL OF MORPHOLOGY, 1998, 36 :55-60
[39]   Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics [J].
Farhad, Tasneem ;
Neves, Keila ;
Arbuthnot, Patrick ;
Maepa, Mohube Betty .
GENES, 2022, 13 (11)
[40]   Improving adenoviral vectors and strategies for prostate cancer gene therapy [J].
Tamura, Rodrigo Esaki ;
de Luna, Igor Vieira ;
Lana, Marlous Gomes ;
Strauss, Bryan E. .
CLINICS, 2018, 73